Policies and Guidelines

• Biologically Active Agents Used in CAM and Placebo Materials--Policy and Guidance
  
  
• Guidelines for NCCAM-supported Clinical Trials
  • Applying for NCCAM Clinical Trials Grants: Points to Consider
  • Considerations for NCCAM Clinical Trial Grant Applications
  • Guidance on Designing Clinical Trials of CAM Therapies: Determining Dose Ranges
  • NCCAM Terms of Awards for Clinical Trials
  • NIH Policy on Data and Safety Monitoring Boards
  • Data and Safety Monitoring Guidelines for NCCAM-supported Clinical Trials
  • Phase III Clinical Trials
    
  • Adverse Events
    
    
• Human Subjects and Animal Protection
  • Certificates of Confidentiality (NIH)
  • Office for Human Research Protections, DHHS
  • Required Education in the Protection of Human Research Participants, NIH
  • FAQ on Required Education in the Protection of Human Research Participants
  • Human and Animal Subject Protection (PDF)
  • Office of Animal Care and Use, NIH
    
    
• NIH Grants Policy Statement
  
  
• Policy Notices

Note: The PDF file requires a viewer such as Adobe Reader, which you can download free of charge from the Adobe Web site.